ClinicalTrials.govpublic full text
THE EFFECT OF CYP3A5 GENOTYPE ON THE PHARMACOKINETICS OF MARAVIROC
healthy subjects, maraviroc, cyp3a5, pharmacokinetics, pharmacogenomics, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 866800
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.